Clinical Trial

A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase 1, open label study in healthy male participants to study the Absorption, Distribution, Metabolism, and Excretion of \[14C\]-MRM-3379 drug following a single oral dose.
Trial Details
NCT Number NCT07712718
Lead Sponsor Mirum Pharmaceuticals, Inc.
Conditions Healthy Volunteers
Enrollment 8 participants
Start Date 2026-05-29
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-17